NCT07436312Recruiting
Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
Impact of a Mixed Intervention Aiming to Decrease the Consumption of Ultra-processed Foods on the Global Diet Quality in Individuals at High Risk of Cancer
Source: ClinicalTrials.gov · Last updated 8 May 2026
Brief summary (registry, in English)
The U-TRANS study was initiated by Gustave Roussy, which is its sponsor\*. It is part of the Interception Program and aims to reduce the consumption of ultra-processed foods in order to improve the overall quality of the diet among people at high risk of cancer (WCRF score ≤ 5, corresponding to low adherence to nutritional cancer prevention recommendations: eating a diet rich in whole grains, vegetables, fruit and fibre, and limiting ultra-processed foods, red meat, processed meats, sugary drinks and alcohol). It assesses the impact of a digital intervention (based on the use of the Open Food Facts app) as a complement to the nutritional education provided by the Interception program.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 170 (estimated)
- First submitted
- 24 Nov 2025
- Start date
- 4 May 2026
- Primary completion date
- Sept 2027
- Lead sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Diseases
- Pancreatic cancer, Colorectal cancer
- NCT number
- NCT07436312
What you commit to
- Study type: Interventional
- Planned participants: 170
- From 4 May 2026 to the primary completion date, Sept 2027
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Psychiatric disorders or cognitive impairments precluding participation,
Other
- Patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent.
Who the study is looking for
- Age \> 18 years,
- Individuals at increased risk of different cancers as defined within the Interception program,
- With a baseline WCRF score ≤ 5 at entry in the Interception program,
- Agreeing to participate and who have given their written agreement for the study,
- Agreeing to fill in the questionnaires on the dedicated platform for the duration of the study,
- Participant have and accept to use their smartphone,
- All participants must understand spoken and written French language
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut Sainte-Catherine Coordinator of this site? Confirm its status | Avignon | France | Not yet recruiting |
| Eugène Marquis Coordinator of this site? Confirm its status | Rennes | France | Recruiting |
| Gustave Roussy Coordinator of this site? Confirm its status | Villejuif | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.